Literature DB >> 27639346

Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state.

Felix Schneider1, Michael Grimm1, Mirko Koziolek1, Christiane Modeß2, Anne Dokter2, Tarek Roustom2, Werner Siegmund2, Werner Weitschies3.   

Abstract

In the present study temperature, pH and pressure profiles of nine healthy human volunteers were investigated after ingestion of the SmartPill® under conditions simulating the fasted state treatment in bioavailability and bioequivalence studies. In a previously published study the same subjects received the SmartPill® under fed conditions as recommended by the FDA. Since large non-digestible objects are mainly emptied during phase III of the interdigestive migrating motor complex, the gastric residence time of the SmartPill® was found to be clearly shorter under fasting conditions. Intragastric pH values during the initial 5min were similar with an identical median value of pH 4.6. Interestingly, the median lowest observed intragastric pH value in fasted state was about one pH unit higher than that under fed conditions. Highest pressure activity was observed within the stomach, in relation to gastric emptying. In fasted state, pressure values upon gastric emptying varied strongly between 30mbar and 304mbar, whereas after fed state ingestion values of at least 240mbar could always be observed. The data showed highly variable gastrointestinal parameters even under fasting conditions which must be considered when evaluating clinical studies and developing biorelevant in vitro test methods especially for large non-disintegrating dosage forms.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Food effect; GI tract; Pressure; SmartPill; Temperature; Transit time; pH

Mesh:

Substances:

Year:  2016        PMID: 27639346     DOI: 10.1016/j.ejpb.2016.09.009

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

Review 1.  Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.

Authors:  Timothy R Lex; Jason D Rodriguez; Lei Zhang; Wenlei Jiang; Zongming Gao
Journal:  AAPS J       Date:  2022-03-11       Impact factor: 4.009

2.  Comparison of In Vitro and In Vivo Results Using the GastroDuo and the Salivary Tracer Technique: Immediate Release Dosage Forms under Fasting Conditions.

Authors:  Maximilian Sager; Philipp Schick; Magdalena Mischek; Christian Schulze; Mahmoud Hasan; Marie-Luise Kromrey; Hassan Benameur; Martin Wendler; Mladen Vassilev Tzvetkov; Werner Weitschies; Mirko Koziolek
Journal:  Pharmaceutics       Date:  2019-12-07       Impact factor: 6.321

3.  E40 glutenase detoxification capabilities of residual gluten immunogenic peptides in in vitro gastrointestinal digesta of food matrices made of soft and durum wheat.

Authors:  Gianfranco Mamone; Maria Cristina Comelli; Serena Vitale; Luigia Di Stasio; Katharina Kessler; Ilaria Mottola; Francesco Siano; Linda Cavaletti; Carmen Gianfrani
Journal:  Front Nutr       Date:  2022-09-08

4.  Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial.

Authors:  Ewelina Juszczyk; Kamil Kisło; Paweł Żero; Ewa Tratkiewicz; Maciej Wieczorek; Jadwiga Paszkowska; Grzegorz Banach; Marcela Wiater; Dagmara Hoc; Grzegorz Garbacz; Jaroslaw Sczodrok; Dorota Danielak
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

5.  Identification of beagle food taking patterns and protocol for food effects evaluation on bioavailability.

Authors:  Guoqing Zhang; Caifen Wang; Li Wu; Jian Xu; Xiaoxiao Hu; Shailendra Shakya; Yuanzhi He; Xiaohong Ren; Weidong Chen; Jiwen Zhang
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

6.  The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.

Authors:  Adrian Rump; Franziska N Weiss; Louisa Schulz; Marie-Luise Kromrey; Eberhard Scheuch; Mladen V Tzvetkov; Tyler White; Shane Durkee; Kevin W Judge; Vincent Jannin; Aouatef Bellamine; Werner Weitschies; Michael Grimm
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.